Urologist Dr. W. Bruce Shingleton, an expert in minimally invasive treatments for prostate and kidney cancers, has been named Director of Endourology at Georgia Health Sciences Health System. In addition, he joins the faculty of Georgia Health Sciences University as a Professor of Urology in the Department of Surgery.
Shingleton specializes in cryotherapy (killing tumor cells by freezing them) and GreenLight Photo-Selective Vaporization, or "green light laser," a new, minimally invasive surgical technique for treating enlargement of the prostate. These treatment options target patients with recurrent cancer and those whose medical condition precludes traditional surgery.
Shingleton also treats kidney stones using advanced endoscopic management. His research interests include minimally invasive cryoablation of renal tumors and the molecular genetics of renal cell carcinoma arising from end-stage renal kidney disease.
Shingleton received his medical degree from the East Carolina University and a master’s degree in public health from the University of South Carolina. He completed postgraduate training at Emory University School of Medicine, Duke University Medical Center, University of Minnesota and Case Western Reserve University. He comes to GHSU from Ochsner Health System in Baton Rouge, La.
Shingleton is a reviewer for the Journal of Urology, the British Journal of Urology and the Journal of Endourology.
He is a member of the American Urological Association and its Southeastern Section; the Society of University Urologists; American College of Surgeons; Endourological Society; and the Georgia Urological Association.